AABH (aspartyl (asparaginyl) [beta]-hydroxylase) as a serum biomarker for colorectal cancer diagnosis and prognosis.

被引：0
|
作者：
Moshiri, Mahmood [1 ]
Moshiri, Arsha [1 ]
Moshiri, Kiarash [1 ]
机构：
[1] Next Pharma Inc, Richmond Hill, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 03期
关键词：
D O I：
10.1200/JCO.2021.39.3_suppl.22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
22
引用
收藏
页数：2
相关论文
共 50 条
  • [21] MicroRNA-552 in colorectal cancer with poor prognosis. Its role as a novel molecular biomarker
    Scano, A.
    Ratto, D.
    Occhinegro, A.
    Pedroncelli, A.
    Rossi, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (05) : 1171 - 1174
  • [22] Angiopoietin-like protein 2 as a novel serum biomarker for diagnosis and prognosis in patients with colorectal cancer
    Kitajima, Takahito
    Toiyama, Yuji
    Shimura, Tadanobu
    Ide, Shozo
    Imaoka, Hiroki
    Kondo, Satoru
    Kawamura, Mikio
    Okugawa, Yoshinaga
    Kawamoto, Aya
    Hiro, Junichiro
    Saigusa, Susumu
    Ohi, Masaki
    Tanaka, Koji
    Inoue, Yasuhiro
    Mohri, Yasuhiko
    Yoshitaka, Sekido
    Kusunoki, Masato
    CANCER RESEARCH, 2014, 74 (19)
  • [23] The distribution and expression profiles of human Aspartyl/Asparaginyl beta-hydroxylase in tumor cell lines and human tissues
    Yang, Hui
    Song, Kai
    Xue, Tian
    Xue, Xiao-Ping
    Huyan, Ting
    Wang, Wei
    Wang, Hua
    ONCOLOGY REPORTS, 2010, 24 (05) : 1257 - 1264
  • [24] Multigene mutation signatures in colorectal cancer patients: Predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang, Yan
    Wang, Hailong
    Jiang, Da
    Li, Ying
    Tian, Caijuan
    Xu, Zanmei
    Su, Meina
    Wang, Xiaowei
    Zhang, Jiangyan
    Hu, Yuanjing
    Liu, Pengfei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [25] INVERTEBRATE ASPARTYL ASPARAGINYL BETA-HYDROXYLASE - POTENTIAL MODIFICATION OF ENDOGENOUS EPIDERMAL GROWTH FACTOR-LIKE MODULES
    MONKOVIC, DD
    VANDUSEN, WJ
    PETROSKI, CJ
    GARSKY, VM
    SARDANA, MK
    ZAVODSZKY, P
    STERN, AM
    FRIEDMAN, PA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 189 (01) : 233 - 241
  • [26] IDENTIFICATION OF ACTIVE-SITE RESIDUES IN BOVINE ASPARTYL (ASPARAGINYL) BETA-HYDROXYLASE BY SITE-DIRECTED MUTAGENESIS
    MCGINNIS, K
    VANDUSEN, WJ
    KU, G
    STERN, AM
    FRIEDMAN, PA
    FASEB JOURNAL, 1994, 8 (07): : A1369 - A1369
  • [27] Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer
    Liu, Rui
    Chen, Xi
    Du, Yiqi
    Yao, Weiyan
    Shen, Lin
    Wang, Cheng
    Hu, Zhibin
    Zhuang, Rui
    Ning, Guang
    Zhang, Chunni
    Yuan, Yaozong
    Li, Zhaoshen
    Zen, Ke
    Ba, Yi
    Zhang, Chen-Yu
    CLINICAL CHEMISTRY, 2012, 58 (03) : 610 - 618
  • [28] Classics to diagnostics: Assessing EMT biomarkers in colorectal cancer prognosis.
    Patel, Rohin
    Robertson, Angelique
    Saxena, Anjana
    Patel, Mintoo
    CANCER RESEARCH, 2021, 81 (13)
  • [29] A meta-analysis of microsatellite instability and colorectal cancer prognosis.
    Popat, S
    Hubner, R
    Houlston, RS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 853S - 853S
  • [30] Inhibition of cancer cell proliferation, motility and invasiveness by monoclonal antibodies specific for human aspartyl (asparaginyl) β-hydroxylase (HAAH).
    Lebowitz, MS
    Finney, AH
    Nelson, VM
    Vasauskas, AA
    Ghanbari, K
    Deutch, AH
    Ghanbari, HA
    CLINICAL CANCER RESEARCH, 2001, 7 (11) : 3784S - 3784S
12345